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Abstract 
Background and aim: Retinal vessel abnormalities are associated with cardiovascular 
disease (CVD) risk. To date, there are no trials investigating the effect of dietary factors on 
the retinal microvasculature. This study examined the dose response effect of fruit and 
vegetable (FV) intake on retinal vessel caliber in overweight adults at high CVD risk. 
Methods and results: Following a 4 week washout period, participants were randomized to 
consume either 2 or 4 or 7 portions of FV daily for 12 weeks. Retinal vessel caliber was 
measured at baseline and post-intervention. A total of 62 participants completed the study. 
Self-reported FV intake indicated good compliance with the intervention, with serum 
concentrations of zeaxanthin and lutein increasing significantly across the groups in a dose-
dependent manner (P for trend < 0.05). There were no significant changes in body 
composition, 24-hour ambulatory blood pressure or fasting blood lipid profiles in response to 
the FV intervention. Increasing age was a significant determinant of wider retinal venules (P 
= 0.004) whereas baseline systolic blood pressure was a significant determinant of narrower 
retinal arterioles (P = 0.03). Overall, there was no evidence of any short-term dose-response 
effect of FV intake on retinal vessel caliber (CRAE (P = 0.92) or CRVE (P = 0.42)).  
Conclusions: This study demonstrated no effect of increasing FV intake on retinal vessel 
caliber in overweight adults at high risk of developing primary CVD. Clinical Trial 
registration: NCT00874341. 
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Introduction 
Cardiovascular disease (CVD) is the leading cause of death worldwide [1] and diet is known 
to play a pathogenic role in CVD development [2]. Fruit and vegetables (FV) represent the 
most botanically diverse food group with potential bioactive properties believed to offer 
vascular protection [3]. A minimum intake of 400g FV per day (equivalent to 5 portions 
excluding potatoes) is recommended as an effective strategy for primary CVD prevention [4], 
which is supported by observational data [5] and confirmed by meta-analyses [6, 7]. While 
an effect of increased FV intake on CVD events has yet to be demonstrated, there is some 
evidence of a beneficial effect of increased FV intake on known markers of CVD risk [2] 
including vascular function [8].  
Microvascular disease has been implicated in the early development of CVD and may be 
reversible [9]. Therefore, strategies to improve microvascular health are of major public 
interest for CVD prevention. A recent clinical intervention study in hypertensive adults 
demonstrated a significant improvement in microvascular function with increasing FV intake 
in a dose-response manner [8]. In this study, microvascular function was determined by a 
trained clinician using a high risk, invasive procedure involving brachial artery cannulation 
and assessment of forearm blood flow response to administration of acetylcholine.  
The retinal microvasculature is the only vascular bed that can be directly visualized in vivo 
and may provide a non-invasive, surrogate method of assessing microvascular health. It is 
possible that changes in the retinal microvasculature reflect structural or functional changes 
in the overall systemic microcirculation. Observational studies have linked structural changes 
in the retinal vessels with established CVD risk factors, including hypertension, obesity and 
diabetes [10-12]. Furthermore, meta-analyses of prospective studies have reported 
significant associations between narrower retinal arterioles and wider retinal venules and 
increased coronary heart disease risk [13] and stroke risk [14]. Intriguingly, small clinical 
trials have demonstrated retinal vessel abnormality regression with low density lipoprotein 
apheresis in hypercholesterolaemic patients [15, 16] and differential effects of 
antihypertensive medications on the retinal vessels [17]. These data suggest that the retinal 
microvasculature is dynamic and can respond favourably to drug treatments.  
Diet may also influence the retinal vessel caliber but study data are limited to cross-sectional 
observations. These studies have reported inverse relationships between retinal vessel 
abnormalities and some dietary constituents such as dietary fibre [18], fish [19] and dairy 
intake [20]. However, adherence to a healthy or unhealthy derived dietary pattern was not 
found to be related to retinal vessel caliber measurement in European older adults [21]. To 
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our knowledge, there are no published intervention studies examining the effect of dietary 
constituents on retinal vessel diameter.  
In this study, we examined the dose-response effect of a randomized short-term FV intake 
intervention on retinal vessel caliber in healthy, overweight individuals at high CVD risk.  
 
Methods 
Study population 
Details of this dietary intervention trial have been reported elsewhere [22]. Adults without 
existing diabetes mellitus and CVD but ≥ 20% CVD risk over the next 10 years as defined by 
Joint British Societies’ Guidelines on prevention of CVD in clinical practice [23] and with a 
Body Mass Index (BMI) ≥ 27 and ≤ 35 kg/m2 and low habitual FV consumption (≤ 2 portions 
per day) were recruited from medical outpatient clinics and from the general public.  
 
Study design 
This was a parallel group randomized controlled trial. The Office for Research Ethics 
Committees Northern Ireland provided ethical approval for this trial according to the 
principles of the Helsinki Declaration. The study protocol was registered on ClinicalTrials.gov 
(NCT00874341) and outcomes were stipulated a priori. All participants provided written 
informed consent for the study.  
Following a 4 week washout period, where FV intake was limited to no more than 2 portions 
per day (1 portion = 80g), participants were block randomized using a computer generated 
number sequence to one of the three intervention groups: 2 or 4 or 7 portions of FV per day 
for the next 12 consecutive weeks. Participants were instructed to keep body weight, 
physical activity and other lifestyle behaviours unchanged during the intervention period. 
Several strategies were used to maximize compliance with the FV intervention. Written 
dietary advice corresponding to the allocated FV group was provided to all participants at 
baseline. Personalized dietetic advice to increase FV intake and encourage FV variety was 
also given to participants allocated to the 4- and 7-portion groups. All participants received a 
weekly FV delivery for the duration of the intervention and were telephoned on a weekly 
basis to monitor compliance and body weight and discuss any individual difficulties with 
adherence to the study protocol.  
 
Study assessments 
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Participants attended a dedicated research facility in the morning following an overnight fast 
for study measurements performed at baseline (week 4) and repeated at the end of the 
intervention (week 16). Demographic and lifestyle data were collected via self-administered 
questionnaires. Anthropometrics including height, weight, waist and hip circumference were 
measured and body mass index (BMI) (kg/m2) was calculated as weight (kg)/height (m)2. 
Total body fat (%) was assessed using whole body Dual Energy X-ray Absorptiometry (DXA) 
(GE Medical Systems, Madison, WI). Blood pressure was measured using 24 hour 
ambulatory blood pressure (Meditech ABPM-04 P.M.S. (Instruments) Ltd, Bershire, UK).  A 
fasting venous blood sample was collected, processed and stored within 2 hours of 
collection at -80°C for analysis.  
Retinal photography was performed by a trained researcher using a Topcon TRC 50 EX 
(Topcon, Tokyo, Japan) digital camera according to a standardized protocol [21]. A color 
stereoscopic fundus image of visual field one (centered on the optic disc); using a field of 
35° at a flash setting of 50mW was captured for each eye after dilation. One trained 
researcher measured the internal retinal vessel diameters from the obtained right eye fundus 
image using a validated semi-automated software program and measurement protocol 
(IVAN, Wisconsin, USA) as used in previous studies [10-14, 21]. In brief, all retinal vessels > 
25 µm coursing through a specified area (0.5-1.0 disc diameter surrounding the optic disc 
zone) were tracked by the software using microdensitometry, and were then identified as 
either arterioles or venules by the researcher. The largest identified arterioles and venules 
were measured in micrometers (µm). The 6 largest arteriole and 6 largest venule diameter 
measurements were combined in an iterative process using validated formulae [24] to 
produce summary indices representing the mean retinal arteriole caliber (CRAE) and mean 
retinal venule caliber (CRVE).  
 
Dietary compliance 
Compliance with the intervention was determined using self-reported dietary data collected 
using a 4-day food record. Reported FV portions consumed by each participant were hand 
counted independently by two researchers from the 4-day food records and any 
discrepancies were assessed and resolved with input from a third researcher.  Self-reported 
FV intake was validated using a panel of nutritional biomarkers as outlined below. 
 
Laboratory analysis 
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Serum concentrations of carotenoid vitamins (lutein, zeaxanthin, β-cryptoxanthin, α-
carotene, β-carotene and lycopene) were measured by high performance liquid 
chromatography with diode array detection [22]. Fasting serum lipid profile (total cholesterol, 
high density lipoprotein (HDL) and triglycerides) were measured using enzymatic assays on 
an ILab-600 biochemical analyser (Instrumentation Laboratories/Werfern, Warrington). Low 
density lipoprotein (LDL) cholesterol was calculated using a standard Friedewald formula. 
Plasma glucose (FPG) was measured using an automated glucose oxidase method using a 
Beckman Glucose Analyser 2. 
 
Statistical analysis 
A power calculation was performed based on the primary endpoint of the trial; insulin 
resistance measured using a euglycaemic-hyperinsulinaemic clamp technique which has 
been reported [22]. In this study, subgroup analyses were carried out for participants with 
valid retinal vessel measurements pre- and post-intervention. Descriptive statistics (means, 
standard deviations and proportions) were used to summarize baseline characteristics of the 
sample according to FV allocation group. Variables that were not normally distributed were 
log transformed prior to statistical analyses and summarized using the geometric mean and 
interquartile range (IQR). Paired t-test analyses were used to determine within group 
changes between baseline and post-intervention measurements. One-way analysis of 
variance with linear trend test was used to examine differences in mean change (i.e. post-
intervention value - pre-intervention value) for measurement variables between groups. 
Analysis of covariance (general linear model) was used to compare retinal vessel caliber 
measurement in response to the FV intervention adjusting for baseline covariates. The 
covariates included age (years), systolic blood pressure (mmHg), smoking status (yes/no) 
and gender (male/female). Significance was defined as a P value ≤ 0.05. All statistical 
analyses were carried out using SPSS version 22.0 (IBM Corp, Armonk, NY). 
 
Results 
A total of 105 participants agreed to take part in this study. During the initial 4 week wash out 
period, 13 (12.4%) withdrew from the study (see Supplemental Figure 1). A total of 92 
participants proceeded to the intervention phase of the study (week 4-16) and 89 
participants completed the study protocol. For this analysis, valid retinal vessel caliber 
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measurements and dietary data were available for 62 study participants at baseline and 
post-intervention (see Supplemental Figure 1 for details). 
Baseline characteristics of the 62 participants (41 male) according to FV allocation are 
shown in Table 1. For the study population the mean (SD) CRAE was 158.2 (14.3) µm and 
mean (SD) CRVE was 235.2 (21.9) µm. Overall, there were no significant differences in any 
of the measured variables between the three FV groups at baseline.  
Change in self-reported FV intake and measured micronutrient status indicated good 
compliance with the intervention.  Self-reported FV did not significantly change from baseline 
in the 2 portions/day group, while reported mean FV intake increased to 3.7 and 7.2 
portions/day within the 4 and 7 portion/day groups respectively (P <0.0001). In addition, 
there were significant between group changes in micronutrient concentration in response to 
the intervention similar to that previously reported [22]. In this sub-study, a significant dose-
response effect of increasing FV intake on lutein (PTrend < 0.0001) and zeaxanthin status 
(PTrend = 0.009) was observed. 
There was no significant change in body weight, total body fat, or markers of CVD risk 
(ambulatory blood pressure variables and serum lipid profiles) between the FV groups as a 
result of the intervention as shown in Table 2. 
Despite good compliance with the intervention, increasing FV intake had no significant effect 
on CRAE or CRVE measurement changes as shown in Table 3. Mean changes in CRAE 
and CRVE measurements were adjusted for baseline covariates (age, gender, smoking 
status and systolic blood pressure) but still showed no evidence of any effect of increasing 
FV intake on retinal vessel caliber. 
In the overall study population, systolic blood pressure was a significant predictor of retinal 
arteriole caliber post intervention (0.4µm narrowing per 1 mmHg; P = 0.03) and age was a 
significant predictor of retinal venule caliber post intervention (0.6µm widening in venule 
diameter per year; P = 0.004) as shown in Table 4.  There were no further significant 
associations between retinal vessel caliber measurements and other measured clinical 
variables.   
 
Discussion 
Putative mechanisms for a beneficial role of FV intake for vascular health include an 
increased antioxidant capacity of the diet which can inhibit oxidative stress, reduce 
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endothelial damage and prevent atherosclerosis [3]. To our knowledge, this is the first 
dietary intervention study to test the effect of increasing FV intake on retinal vessel diameter 
measurement.  While self-reported FV intake indicated good compliance with the FV 
intervention and micronutrient status improved in response to the increasing FV intake, there 
was no beneficial effect of increased FV intake on retinal vessel caliber in overweight adults, 
at high risk of developing CVD.   
In contrast a recent clinical intervention study involving hypertensive adults, found a 6% 
improvement in microvascular function with each additional FV portion per day [8]. The 
disparity in findings may be explained by differences in study population, study design and 
methods of examining the microcirculation. In the latter study, microvascular function was 
determined using an established method involving brachial artery cannulation and 
measuring forearm blood flow response to acetylcholine administration: a method shown to 
be valid, reliable and to have prognostic significance in predicting CVD events [25]. 
Quantification of the retinal vessel caliber is a relatively novel method to determine in vivo 
microvascular structure rather than vessel function. While retinal vascular abnormalities are 
contended to parallel changes in other microvascular beds the evidence to support this 
assertion is limited at present [26]. Further research to determine the extent to which the 
retinal microvasculature is a surrogate for microvascular beds in the coronary circulation will 
strengthen the rationale for employing this non-invasive method in clinical studies 
investigating vascular health as an end-point [26].  
Major CVD risk factors such as elevated blood pressure and obesity are known to induce 
similar phenotypic (pro-oxidative, pro-inflammatory, pro-thrombogenic) changes in all 
vascular beds including the microcirculation [27] and these factors have also been linked to 
morphological alteration of the retinal vessels [10, 11]. It is possible that vascular reactivity is 
mediated, in part, by changes in arterial blood pressure. McCall et al [8] reported a non-
significant trend in systolic blood pressure reduction with increasing FV intake. In the present 
study, no significant change in blood pressure measurement was observed in response to 
the FV intervention which may have contributed to the null findings in relation to retinal 
vessel caliber.  
The impact of body weight/composition change on retinal vessel caliber is not yet known. In 
this study, participants were instructed to keep body weight stable during the intervention in 
order to test the specific effect of increasing FV intake on retinal vessel caliber while 
minimizing potential confounding associated with change in body weight or composition. Our 
results indicated that measured body weight and total body fat did not alter significantly in 
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response to increasing FV intake, and therefore cannot be considered a confounding factor 
in the study. 
While the correlation of retinal vessel caliber with other microvascular systems is not fully 
explained at the present time, measurement of the retinal vessels may have relevance in 
terms of CVD risk stratification. Epidemiological studies have shown that narrower retinal 
arterioles are associated with CVD in women and are predictive of future hypertension 
development [13, 28]. Narrow retinal arterioles are most strongly associated with past and 
present blood pressure levels. We found that systolic blood pressure was a significant 
determinant of narrower arterioles in our middle-aged population. Each 1mmHg increase in 
systolic blood pressure was associated with a 0.4µm narrowing in arteriole diameter. The 
magnitude of this association is similar to that reported in other prospective studies in adults; 
each 10mmHg increase in mean arterial BP was associated with a 1.1 µm decrease in 
CRAE [29].  
Wider venules are most strongly associated with increased risk of stroke in both men and 
women and may be predictive of future development of type 2 diabetes and also retinopathy 
in adults with existing diabetes [14, 28]. Systemic determinants of wider venules appear to 
be obesity, blood glucose levels and smoking status. We did not find any relationship 
between BMI and retinal venule caliber which was not surprising considering all study 
participants were selected as being overweight/clinically obese with evidence of abdominal 
obesity. We also did not observe significant associations between retinal venule caliber and 
smoking status or fasting glucose concentrations; however it is possible that the small 
number of current smokers and participants with impaired glucose level in this study 
attenuated any potential associations. Age was the most important determinant of retinal 
venule caliber in our middle-aged population with each 1 year increase in age associated 
with an approximate 0.6µm widening in venule diameter. 
This study has several strengths including the randomized controlled study design and high 
compliance with the FV intervention. In addition, one trained researcher used a validated 
measurement and analysis protocol to objectively measure retinal vessel caliber as 
employed in previous studies [10-14, 21]. Several potential limitations of this study should be 
mentioned. The possibility of measurement error exists as there are several potential 
sources of variation in the quantification of retinal vessel caliber including potential 
confounding effect of refractive and magnification error. However, reliability of this method to 
assess retinal vessels has been previously reported as high, with inter-grader weighted 
kappa of 0.85 and 0.90 and intra-grader weighted kappa between 0.80 and 0.93 for 
arteriolar and venular caliber measurements respectively [26]. Furthermore, coefficients of 
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variation of repeated measures of CRAE and CRVE are reported as less than 2% [30]. 
Unfortunately, we were unable to determine intra-grader variability due to time and cost 
limitations of the study. A second limitation of this study is that retinal vessel caliber was a 
secondary end-point outcome measurement and an optional component of an already 
demanding study protocol. Therefore, the small sample size may limit the study findings. 
However, a retrospective power calculation based on the variability of CRAE and CRVE 
changes from the low (2 portions/day) FV group (SD 14.5 and 16.6µm, respectively) 
suggests that the current study sample size had in excess of 90% power to detect as 
statistically significant (P = 0.05, two-tailed test) a difference of 10% in retinal vessel caliber 
measurements between two groups.  
In conclusion, increased FV intake improved micronutrient status but had no significant 
effect on retinal vessel caliber in adults at high risk of developing CVD. This study supports 
the continued promotion of FV on the basis of improving micronutrient status but not in 
relation to retinal vessel caliber measurement. 
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Table 1: Baseline characteristics of study participants (n=62) according to Fruit and vegetable (FV) group allocation. 
 
 2 portions 
FV/day 
(n=20) 
4 portions 
FV/day 
(n=20) 
7 portions 
FV/day 
(n=22) 
Between group            
P- valuea,b 
Age (years) 56.6 (5.2) 58.2 (5.3) 55.5 (7.7) 0.38 
Males, n (%)b 11 (55) 14 (70) 16 (73) 0.43 
Current smokers, n (%)b 2 (10) 4 (20) 3 (14) 0.66 
Weight (kg) 87.3 (12.4) 87.3 (9.8) 87.5 (9.1) 0.99 
BMI (kg/m2) 31.4 (2.5) 30.9 (2.5) 30.2 (1.8) 0.25 
Waist circumference (cm) 104.2 (8.6) 104.9 (7.4) 102.6 (6.4) 0.61 
Waist to hip ratio 0.96 (0.08) 0.99 (0.06) 0.96 (0.05) 0.34 
Body fat (%) 40.0 (7.3) 36.8 (6.1) 37.0 (6.6) 0.24 
Systolic blood pressure (mmHg) 127.8 (11.0) 126.0 (10.7) 129.4 (9.9) 0.57 
Diastolic blood pressure (mmHg) 75.1 (7.9) 76.6 (6.6) 77.5 (6.6) 0.56 
Total cholesterol (mmol/L) 5.51 (1.02) 5.49 (1.17) 5.60 (1.19) 0.95 
LDL cholesterol (mmol/L) 3.35 (1.00) 3.29 (1.06) 3.51 (1.07) 0.78 
HDL cholesterol (mmol/L) 1.31 (0.23) 1.29 (0.41) 1.25 (0.34) 0.81 
Triglyceride (mmol/L)c 1.93 (1.45, 2.44) 1.85 (1.34, 2.40) 1.70 (1.25, 2.25) 0.59 
Total: HDL cholesterol ratioc 4.19 (3.36, 4.85) 4.32 (3.83, 5.30) 4.53 (3.51, 5.78) 0.62 
Antihypertensive medications, n (%)b 7 (35) 7 (35) 6 (27) 0.82 
Lipid lowering therapy, n (%)b 10 (50) 7 (35) 5 (23) 0.18 
Fasting plasma glucose (mmol/L)d 5.54 (0.50) 5.71 (0.71) 5.44 (0.55) 0.37 
CRAE (µm) 158.9 (12.6) 160.7 (15.5) 155.3 (14.6) 0.46 
CRVE (µm) 228.9 (20.9) 239.8 (20.7) 236.9 (23.4) 0.27 
Fruit and vegetable intake (portionse/day) 1.71 (0.98) 1.70 (0.70) 1.62 (0.81) 0.90 
Fruit and vegetable intake (g/day) 137 (78) 136 (56) 130 (65) 0.90 
 
aBetween group comparisons are made using one-way analysis of variance.bBetween group comparisons for categorical variables are made using Chi Square test with 2 df. 
cSkewed variable logarithmically transformed for analysis and summarised as geometric mean (IQR). dAvailable for 19, 20, 22 participants in the 2-, 4- and 7- portions/day 
group, respectively. e1 portion=80g. FV = Fruit and Vegetables; CRAE = Central Retinal Arteriole Equivalent; CRVE = Central Retinal Venule Equivalent.  
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Table 2: Mean change in clinical measurements in response to intervention (n=62), according to FV allocation. 
 
Variable measureda 
2 portions FV/day (n=20max) 4 portions FV/day (n=20max) 7 portions FV/day (n=22max) Between 
group P 
valuec 
 
PTrendd 
Week 4 Week 16 Change     
(95% CI) 
Week 4 Week 16 Change     
(95% CI) 
Week 4 Week 16 Change 
(95% CI)  
 
Weight (kg) 87.3 (12.4) 87.7 (12.7) 0.49 
(-0.26, 1.23) 
87.3 (9.8) 87.7 (10.1) 0.45 
(-0.28, 1.17) 
87.5 (9.1) 88.0 (9.3) 0.53 
(-0.03, 1.08) 
0.98 0.92 
Body Mass Index (kg/m2) 31.4 (2.5) 31.6 (2.6) 0.15 
(-0.10, 0.40) 
30.9 (2.5) 31.1 (2.7) 0.16 
(-0.09, 0.41) 
30.2 (1.8) 30.4 (1.8) 0.19 
(0.01, 0.38) 
0.97 0.80 
Waist circumference 
(cm) 
104.2 (8.6) 104.9 (8.3) 0.70 
(0.00, 1.40) 
104.4 (7.3) 105.1 (7.3) 0.63 
(-0.53, 1.80) 
102.6 (6.4) 102.8 (6.4) 0.18 
(-1.17, 1.53) 
0.75 0.49 
Waist to hip ratio 0.96 (0.08) 0.97 (0.09) 0.00 
(-0.01, 0.01) 
0.98 (0.06) 0.98 (0.06) 0.00 
(-0.01, 0.01) 
0.96 (0.05) 0.96  (0.05) 0.00  
(-0.01, 0.01) 
0.42 0.25 
Body Fat (%) 40.0 (7.3) 40.4 (7.6) 0.43             
(-0.14, 0.98) 
36.9 (6.3) 37.0 (6.5) 0.08 
(-0.62, 0.79) 
37.6 (6.0) 37.9 (6.4) 0.29 
(-0.24, 0.81) 
0.71 0.74 
Systolic blood pressure 
(mmHg) 
127.8 (11.0) 124.7 (15.0) -3.1                    
(-9.0, 2.8) 
126.0 (10.7) 127.5 (11.4) 1.5                   
(-3.3, 6.3) 
130.4 (9.1) 127.1 (9.0) 3.4                 
   (-6.94, 0.24)  
0.26 0.10 
Diastolic blood pressure 
(mmHg) 
75.1 (7.9) 73.0 (10.1) 2.1                   
(-5.82, 1.62) 
76.6 (6.5) 77.1 (9.0) 0.5                 
(-2.9, 3.8) 
78.0 (6.3) 75.8 (8.2) -2.2                
    (-5.2, 0.8) 
0.43 0.19 
Total cholesterol 
(mmol/L) 
5.51 (1.02) 5.74 (1.14) 0.23                 
(-0.16, 0.61) 
5.49 (1.17) 5.15 (1.06) -0.34                 
(-0.70, 0.02) 
5.60 (1.19) 5.45 (1.10) -0.15                   
(-0.41, 0.11) 
0.05* 0.17 
LDL cholesterol (mmol/L) 3.35 (1.00) 3.58 (1.10) 0.23                 
(-0.09, 0.55) 
3.29 (1.06) 3.07 (0.92) -0.22                
(-0.54, 0.09) 
3.52 (1.10) 3.40 (0.91) -0.11                   
(-0.33, 0.11) 
0.06 0.13 
HDL cholesterol 
(mmol/L) 
1.31 (0.23) 1.34 (0.23) 0.02                 
(-0.07, 0.11) 
1.29 (0.41) 1.24 (0.40) -0.06                
(-0.13, 0.02) 
1.25 (0.34) 1.23 (0.40) -0.02                   
(-0.07, 0.02) 
0.26 0.40 
Triglyceride (mmol/L)b 1.93 
 (1.45, 2.44) 
1.92  
(1.51, 2.43) 
1.00 
 (0.86, 1.16) 
1.85  
(1.34, 2.40) 
1.71  
(1.10, 1.45) 
0.92 
(0.82, 1.04) 
1.70  
(1.25, 2.25) 
1.62  
(1.06, 2.38) 
0.95 
(0.82, 1.11) 
0.74 0.71 
Total:HDL cholesterol 
ratiob 
4.19 
 (3.36, 4.85) 
4.28  
(3.58, 5.02) 
1.02 
 (0.95, 1.09) 
4.32  
(3.83, 5.30) 
4.25  
(3.64, 4.85) 
0.98 
(0.91, 1.06) 
4.53 
(3.51, 5.78) 
4.57  
(3.51, 5.86) 
1.01  
(0.95, 1.07) 
0.74 0.90 
 
aValues are presented as Mean (SD) and change as the difference between week 16 and week 4 mean values (95% CI). bSkewed variable logarithmically transformed for 
analysis and summarised as geometric mean (IQR) and change as ratio of week16 geometric mean to week 4 geometric mean ( (95% CI). cBetween group comparisons are 
made using one-way analysis of variance and  dtest for  linear trend. FV = Fruit and Vegetables. 
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Table 3: Mean change in summary retinal vessel diameters measured in response to a 12 week Fruit and Vegetable (FV) intervention  
 
 
Retinal vessel 
diameter 
measurement 
(µm) 
Unadjusted Mean Change (95% CI)a 
 
Between 
group P-
valueb 
P-
Trendc 
Adjusted Mean Change (95% CI)d P-Trendf 
2 portions 
FV/day 
(n = 20) 
4 portions 
FV/day    
(n = 20) 
7  portions 
FV/day 
(n = 22) 
4 v 2 
portions 
FV/day 
P-
valuee 
7 v 2 
portions 
FV/day 
P-
valuee 
 
CRAE 
 
 
2.4           
(-4.4, 9.2) 
1.3           
(-6.1, 8.6) 
2.9             
(-4.3, 10.1) 0.94 0.92 
-1.8           
(-11.9, 8.2) 0.71 
2.4             
(-7.6, 12.3) 0.64 0.64 
CRVE 7.5           (-0.2, 15.3) 
1.1           
(-8.1, 10.3) 
3.0             
(-4.5, 10.4) 0.50 0.42 
-9.3            
(-20.2, 1.7) 0.10 
-4.0             
(-15.0, 6.9) 0.46 0.25 
 
aVariable summarised as mean change (95%CI) between week 4 and week 16 values, bBetween-group comparisons analysed using one-way analysis of variance and with a 
ctest for linear trend, dMean change in retinal vessel diameters adjusted for baseline covariates (age (y), gender (male/female), systolic blood pressure (mmHg) and smoking 
status (yes/no) and compared using analysis of variancee and with a test for linear trendf. CRAE = Central Retinal Arteriole Equivalent; CRVE = Central Retinal Venule 
Equivalent; FV = Fruit and Vegetables;1 portion=80g. 
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Table 4: Analysis of covariance to compare post-intervention (week 16) retinal vessel caliber (CRAE/CRVE) adjusting for baseline covariates. 
 
 
Baseline Covariate (week 4) 
Post-intervention CRAE (µm) Post-intervention CRVE (µm) 
Coefficient (95% CI) p-value Coefficient (95% CI) p-value 
FV intake 
            4 v 2 (portions/day) 
 
-1.1 (-10.1, 7.9) 
 
0.81 
 
-4.2 (-13.8, 5.4) 
 
0.38 
            7 v 2 (portions/day) 1.1 (-7.8, 10.1) 0.80 -0.5 (-9.9, 8.9) 0.91 
CRAE (µm) 0.5 (0.2,0.8)    <0.001** − − 
CRVE (µm) − − 0.6 (0.4, 0.8) <0.001** 
Age (per year) 0.6 (-0.1, 1.2) 0.08 0.9 (0.3, 1.6) 0.004** 
Systolic blood pressure (per mmHg) -0.4 (-0.8, 0.0) 0.03* -0.2 (-0.6, 0.2) 0.28 
Gender (male v female) -5.8 (-13.8, 2.1) 0.15 0.6 (-7.7, 8.9) 0.88 
Smoking (yes v no) -0.9 (-11.8, 10.1) 0.87 -7.0 (-18.4, 4.4) 0.23 
CRAE = Central Retinal Arteriole Equivalent; CRVE = Central Retinal Venule Equivalent; FV = Fruit and Vegetables; 1 portion = 80g. * p ≤0.05; **p ≤0.0. 
 
